Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer
Clinical trial NCT04906993 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04906993
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2025-06-10
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.